Healtcare Rivastigmine Market Click to read
  • Comments

Healtcare

Rivastigmine Market

Published on in “Health & Fitness”, language — English. 3 pages.
Rivastigmine is a cholinesterase enzyme inhibitor, which acts on butylcholinesterase and acetylcholinesterase. It is a cholinergic agent that aids in the treatment of Alzheimer’s and Parkinson’s disease. More

Other publications of “Healtcare”

View all publications